Abstract
Rose and colleagues1 found that the DINAMAP models 1846-SX and 1846-SX/P (Critikon Corp) systematically skip 14 values of systolic blood pressure, of which some (140 and 160 mm Hg) are critical in the diagnosis and treatment of hypertension. The findings of Rose and colleagues1 come as no surprise. The DINAMAP 8100 failed to pass validation.2 Furthermore, to protect their intellectual and commercial interests, most−if not all−manufacturers of blood pressure monitors operate in secrecy. Against current recommendations,3 they modify the technical specifications and software of devices without notice or fail to subject new or modified devices to independent peer-reviewed validation in a timely manner.4 Guideline …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
